Semjonow A - Search Results

1

Exploring prostate cancer genome reveals simultaneous losses of PTEN, FAS and PAPSS2 in patients with PSA recurrence after radical prostatectomy.

Ibeawuchi C, Schmidt H, Voss R, Titze U, Abbas M, Neumann J, Eltze E, Hoogland AM, Jenster G, Brandt B, Semjonow A. Ibeawuchi C, et al. Among authors: semjonow a. Int J Mol Sci. 2015 Feb 11;16(2):3856-69. doi: 10.3390/ijms16023856. Int J Mol Sci. 2015. PMID: 25679447 Free PMC article.

2

Prediction of tumor recurrence after radical prostatectomy using elimination kinetics of prostate-specific antigen.

Semjonow A, Hamm M, Rathert P. Semjonow A, et al. World J Urol. 1993;11(4):218-20. doi: 10.1007/BF00185073. World J Urol. 1993. PMID: 7508787

3

Elimination kinetics of prostate-specific antigen serum and urine.

Semjonow A, Hamm M, Rathert P. Semjonow A, et al. Int J Biol Markers. 1994;9(1):15-20. doi: 10.1177/172460089400900103. Int J Biol Markers. 1994. PMID: 7519649

4

[Different determination methods make interpretation of prostate-specific antigen more difficult].

Semjonow A, Brandt B, Oberpenning F, Hertle L. Semjonow A, et al. Urologe A. 1995 Jul;34(4):303-15. Urologe A. 1995. PMID: 7545845 Review. German.

5

Isolation of prostate-derived single cells and cell clusters from human peripheral blood.

Brandt B, Junker R, Griwatz C, Heidl S, Brinkmann O, Semjonow A, Assmann G, Zänker KS. Brandt B, et al. Among authors: semjonow a. Cancer Res. 1996 Oct 15;56(20):4556-61. Cancer Res. 1996. PMID: 8840959

6

Measurement of prostate-specific antigen: no advantage to ultrasensitive assays?

Junker R, Brandt B, Semjonow A, Assmann G. Junker R, et al. Among authors: semjonow a. J Natl Cancer Inst. 1996 Nov 6;88(21):1594-5. doi: 10.1093/jnci/88.21.1594. J Natl Cancer Inst. 1996. PMID: 8901859 No abstract available.

7

Discordance of assay methods creates pitfalls for the interpretation of prostate-specific antigen values.

Semjonow A, Brandt B, Oberpenning F, Roth S, Hertle L. Semjonow A, et al. Prostate Suppl. 1996;7:3-16. Prostate Suppl. 1996. PMID: 8950358 Review.

8

Impact of free prostate-specific antigen on discordant measurement results of assays for total prostate-specific antigen.

Semjonow A, Oberpenning F, Brandt B, Zechel C, Brandau W, Hertle L. Semjonow A, et al. Urology. 1996 Dec;48(6A Suppl):10-5. doi: 10.1016/s0090-4295(96)00604-8. Urology. 1996. PMID: 8973694 Clinical Trial.

9

The use of prostate-specific antigen (PSA) for the monitoring of radiation therapy in prostate cancer.

Schäfer U, Micke O, Hampel G, Brandt B, Bovenschulte A, Semjonow A, Willich N. Schäfer U, et al. Among authors: semjonow a. Anticancer Res. 1997 Jul-Aug;17(4B):2983-6. Anticancer Res. 1997. PMID: 9329581

10

The biologic lower detection limit of six ultrasensitive PSA assays.

Junker R, Brandt B, Semjonow A, Erren M, Zechel C, Assmann G. Junker R, et al. Among authors: semjonow a. Anticancer Res. 1999 Jul-Aug;19(4A):2625-8. Anticancer Res. 1999. PMID: 10470206

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters